Los Angeles Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Los Angeles Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,598	Closed	-$150K	–	1519
2021 Q4	$150K	Sell	12,598 -137	-1%	-$1.58K	﹤0.01%	1360
2021 Q3	$145K	Sell	12,735 -32,832	-72%	-$451K	﹤0.01%	1442
2021 Q2	$817K	Sell	45,567 -24,163	-35%	-$389K	﹤0.01%	941
2021 Q1	$1.08M	Buy	69,730 +10,835	+18%	+$157K	﹤0.01%	862
2020 Q4	$719K	Buy	58,895 +3,902	+7%	+$54.4K	﹤0.01%	1067
2020 Q3	$707K	Buy	54,993 +3,812	+7%	+$32.9K	﹤0.01%	948
2020 Q2	$520K	Buy	51,181 +21,231	+71%	+$195K	﹤0.01%	1098
2020 Q1	$243K	Buy	+29,950	New	+$259K	﹤0.01%	1125

Other funds holding MRNS

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Los Angeles Capital Management's MRNS Position: Q1 2022 in Review

Los Angeles Capital Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2022, closing a stake of 12,598 shares — an estimated $150K sold.

Los Angeles Capital Management first reported a position in MRNS in Q1 2020 and held it in 8 quarters. The position peaked at $1.08M in Q1 2021. 83 funds tracked by Wall St. Rank hold MRNS as of Q1 2022.

Los Angeles Capital Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2022 after selling out during the quarter.
Los Angeles Capital Management sold 12,598 Marinus Pharmaceuticals, Inc shares in Q1 2022, an estimated $150K.
Los Angeles Capital Management first reported a position in Marinus Pharmaceuticals, Inc in Q1 2020 and held it in 8 quarters.
Los Angeles Capital Management's Marinus Pharmaceuticals, Inc position peaked at $1.08M in Q1 2021.
83 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2022.

Based on Los Angeles Capital Management's 13F filing for Q1 2022, filed 6 May 2022.